An update on bimatoprost in glaucoma therapy (Q35020542)

5 August 2017

1 reference

title

An update on bimatoprost in glaucoma therapy (English)

1 reference

5 August 2017

Louis B Cantor

1

1 reference

PubMed ID

12472372

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Expert Opinion on Pharmacotherapy

5 August 2017

1 reference

5 August 2017

3

1 reference

5 August 2017

12

1 reference

5 August 2017

1753-1762

1 reference

Number of people with glaucoma worldwide

5 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Intraocular pressure-dependent progression of visual field loss in advanced primary open-angle glaucoma: a 15-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Diurnal intraocular pressure variations: an analysis of 690 diurnal curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Target pressure--glaucomatologists' holey grail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Medical treatment of glaucoma--a reappraisal of the risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Bimatoprost and its free acid are prostaglandin FP receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Cystoid macular edema associated with ocular hypotensive lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

Effect of temperature and light on the stability of latanoprost and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.12.1753

10.1517/14656566.3.12.1753

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12472372